News – Page 1172 – Endpoints News

Merck KGaA: This time we’ve got our R&D act together (seriously)

9 years ago

TG Therapeutics maps a shortcut to the FDA with lead drug for CLL

9 years ago

Regeneron picks a new delivery tech in effort to upgrade flagship blockbuster Eylea

9 years ago

Leerink analyst adjusts nusinersen peak to $2.5B; Daiichi Sankyo signs up to work with Dana-Farber team

9 years ago

Adaptimmune looks to salvage ovarian cancer study by adding fludarabine to prep patients

9 years ago

AzurRx clips its IPO price, but manages to get the job done

9 years ago

Tiny RXi bags an option to buy CAR-T fledgling MirImmune

9 years ago

Say what? Compassionate use program? What compassionate use program?

9 years ago

AstraZeneca records another R&D setback, triggering a meltdown at Synairgen

9 years ago

The promise of designer microbes inspires a $130M mega-round for Zymergen

9 years ago

Auris tries to rebound from PhIII failure with new trial design; Kymab ties the knot with Shanghai-based EpimAb

9 years ago

Illumina shares tank after sequencing giant falls short on revenue

9 years ago

Novartis-backed Gamida Cell grabs a breakthrough trophy for experimental cell treatment

9 years ago

Supernus gets a (temporary) boost as ADHD drug clears PhIIb hurdle

9 years ago

Deaths, accusations of insider trading and an early warning from Boehringer stir Hanmi controversy

9 years ago

GSK attempts to remake itself in China with local ties

9 years ago

#ESMO16: Boehringer drug flops on OS endpoint; Medivir reorganizes, cuts staff

9 years ago

The Sarepta dilemma: Bioethics expert Arthur Caplan says it’s time to rethink how to regulate compassion

9 years ago

Takeda adds a $790M discovery deal to an ongoing R&D overhaul

9 years ago

Helsinn sets up a boutique investment fund with a roving eye for oncology upstarts

9 years ago

Merck’s glorious victory in lung cancer marks a Russian winter for Bristol-Myers

9 years ago

Novartis heads to the finish line with CDK 4/6 blockbuster contender ribociclib

9 years ago

Tesaro makes its case for a clean sweep with niraparib - and shares soar again

9 years ago

Kite touts 12-month remission data from tiny CAR-T study; Ironwood exec dies in bike accident

9 years ago

First page Previous page 1169 1170 117111721173 1174 1175 Next page Last page